Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TREAT B”

4,707 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,707 results

Early research (Phase 1)Study completedNCT00470405
What this trial is testing

Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma

Who this might be right for
LymphomaSolid Tumor
Vanderbilt-Ingram Cancer Center 25
Not applicableUnknownNCT04211805
What this trial is testing

Maternal Therapy With TAF Versus TDF to Prevent Vertical Transmission of Hepatitis B

Who this might be right for
Hepatitis B, ChronicPregnancy Related
New Discovery LLC 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT06552572
What this trial is testing

Glofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma
Samsung Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00022477
What this trial is testing

BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Chicago 24
Very early researchUnknownNCT05747157
What this trial is testing

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r B-ALL Clinical Research

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Anhui Provincial Hospital 18
Large-scale testing (Phase 3)Study completedNCT00117676
What this trial is testing

Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 382
Testing effectiveness (Phase 2)Study completedNCT02646189
What this trial is testing

Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients

Who this might be right for
Hepatitis B, Chronic
Replicor Inc. 12
Not applicableStudy completedNCT03350074
What this trial is testing

HBV Envelope Proteins Variability on HBs Antigen Clearance Under Nucleos(t)Ide Analogue Therapy

Who this might be right for
Hepatitis B, Chronic
Central Hospital, Nancy, France 19
Large-scale testing (Phase 3)Study completedNCT00005590
What this trial is testing

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more
Cancer Research Campaign Clinical Trials Centre
Testing effectiveness (Phase 2)Study completedNCT03744676
What this trial is testing

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

Who this might be right for
Lymphoma, Non-HodgkinLymphomaLymphoma, B-Cell+7 more
Juno Therapeutics, a Subsidiary of Celgene 104
Early research (Phase 1)Study completedNCT00006340
What this trial is testing

Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

Who this might be right for
LeukemiaLymphomaPrecancerous Condition+1 more
Boston Medical Center
Not applicableUnknownNCT05975190
What this trial is testing

Respiratory Training and Relaxation Techniques to Improve Adjuvant Radiation Therapy in DIBH in Breast Cancer

Who this might be right for
RadiotherapyBreast CancerRelaxation+1 more
Technical University of Munich 108
Testing effectiveness (Phase 2)Looking for participantsNCT06918990
What this trial is testing

Treatment of Antibody-Mediated Rejection (ABMR) With CarBel

Who this might be right for
Kidney Transplant Rejection
National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Ended earlyNCT02378038
What this trial is testing

PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)

Who this might be right for
Richter's Transformation
Sierra Oncology LLC - a GSK company 5
Testing effectiveness (Phase 2)Looking for participantsNCT06792825
What this trial is testing

HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL

Who this might be right for
Follicular LymphomaMarginal Zone Lymphoma
Masonic Cancer Center, University of Minnesota 65
Large-scale testing (Phase 3)Looking for participantsNCT06188676
What this trial is testing

Multicenter Study of Safety and Efficacy Nivolumab at the Fixed Dose 40 mg (Nivo40) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed PMBL

Who this might be right for
Primary Mediastinal Lymphoma
National Research Center for Hematology, Russia 100
Testing effectiveness (Phase 2)Study completedNCT00720876
What this trial is testing

Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 30
Early research (Phase 1)Study completedNCT04629976
What this trial is testing

Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Nucorion Pharmaceuticals, Inc. 21
Early research (Phase 1)Looking for participantsNCT06539338
What this trial is testing

Investigate Safety of INT2104 Infusions in Participants Aged 18 Years of Age and Older Who Have B-cell Cancers That Came Back After Previous Treatment

Who this might be right for
Lymphomas Non-Hodgkin's B-CellPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Kite, A Gilead Company 34
Testing effectiveness (Phase 2)Looking for participantsNCT06462248
What this trial is testing

Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies

Who this might be right for
Lymphoma, NonhodgkinLeukemia, Lymphocytic
Chi Kong Li 20
Load More Results